Home › Funds › BVF INC/IL › MIRM

BVF INC/IL position in MIRM

MIRUM PHARMACEUTICALS INC · Health Care

BVF INC/IL reported holding 1,056,027 shares of MIRM (MIRUM PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$123.6M, representing 3.16% of its reported portfolio and ranking #8 among its reported holdings. BVF INC/IL has disclosed MIRM holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)1.06M sh
Reported value held$123.63M
Portfolio Weight3.16%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How BVF INC/IL's MIRM position evolved

BVF INC/IL first disclosed a stake in MIRM in Q3 2023 at 4,370,024 shares (US$138.1M). The position peaked in Q2 2024 at 4,370,024 shares, worth US$149.4M. Across 12 filings, BVF INC/IL increased the stake 1 time(s), trimmed it 5 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 1,056,027 shares valued at US$123.6M — a reduction of -528,700 shares quarter over quarter.. Notable position changes include a 30% trim in Q3 2024 (shares rose 6% over the following quarter), a 46% trim in Q3 2025 (shares rose 8% over the following quarter), a 33% trim in Q2 2026 (shares fell 27% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 4.37M $138.09M New
Q4 2023 4.37M $129.00M Hold
Q1 2024 4.37M $109.78M Hold
Q2 2024 4.37M $149.41M Hold
Q3 2024 3.08M $119.96M Reduce
Q4 2024 2.80M $115.64M Reduce
Q1 2025 2.80M $125.98M Hold
Q2 2025 2.76M $140.52M Reduce
Q3 2025 1.50M $109.62M Reduce
Q4 2025 1.50M $118.11M Hold
Q1 2026 1.58M $146.40M Add
Q2 2026 1.06M $123.63M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MIRM and 13F data

MIRM (MIRUM PHARMACEUTICALS INC) is a Health Care company. 61 other funds we track also report a position in MIRM — the largest reported positions include Frazier Life Sciences Management, L.P. (US$899.1M), EVENTIDE ASSET MANAGEMENT, LLC (US$146.2M), TANG CAPITAL MANAGEMENT LLC (US$144.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MIRM

All MIRM fund holders →

FAQ

How long has BVF INC/IL held MIRM?

BVF INC/IL has disclosed MIRM holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is BVF INC/IL's current position in MIRM?

As of Q2 2026, BVF INC/IL holds 1.06M shares of MIRM (MIRUM PHARMACEUTICALS INC), valued at $123.63M, representing 3.16% of its reported portfolio and ranking #8.

Has BVF INC/IL been buying or selling MIRM?

In the latest 13F filing (Q2 2026), BVF INC/IL reduced its position in MIRM. The position peaked in Q2 2024 at 4.37M shares.

Which other funds hold MIRM?

Other major institutional holders of MIRM include Frazier Life Sciences Management, L.P., EVENTIDE ASSET MANAGEMENT, LLC, TANG CAPITAL MANAGEMENT LLC, among 61 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.